510(k) K210335

Blood Administration Set by Baxter Healthcare Corporation — Product Code BRZ

K210335 is an FDA 510(k) premarket notification submitted by Baxter Healthcare Corporation for the device "Blood Administration Set". The FDA issued a decision of Substantially Equivalent on June 10, 2021. The device falls under product code BRZ (Set, Blood Transfusion), a Class II device regulated under 21 CFR 880.5440. Baxter Healthcare Corporation has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
June 10, 2021
Date Received
February 5, 2021
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Set, Blood Transfusion
Device Class
Class II
Regulation Number
880.5440
Review Panel
HO
Submission Type